Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p173
Academic Journal
The article focuses on an observational study, which explores the prevalence of metabolic syndrome (MetS) in adult in- and outpatients with untreated or treated schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics. The background, methods, results, and conclusions of the study, are discussed.


Related Articles

  • Correlation of Metabolic Syndrome with IL-27 in the Patients with Schizophrenia. Andarzi, Salar; Hajinejad, Salah; Miri, Hamid Reza // Journal of Fasting & Health;Winter2019, Vol. 7 Issue 1, p1 

    Introduction: Growing evidence suggests that antipsychotic drugs affect the level of cytokines and metabolic syndrome parameters in schizophrenic patients. The present study aimed to investigate the serum markers of metabolic syndrome, including low-density lipoprotein (LDL), high-density...

  • Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.  // BMC Psychiatry;2011, Vol. 11 Issue 1, p167 

    The article focuses on a study, which aims to assess the effectiveness outcomes in a real-world setting in schizophrenics initiating risperidone long-acting therapy (RLAT). The study was a 24-month, multicenter, prospective, longitudinal, observational study. It is concluded that improvements...

  • DURATION OF ILLNESS, SYMPTOMS AND FUNCTIONAL RECOVERY IN PATIENTS SUFFERING FROM SCHIZOPHRENIA. Nazar, Zahid; Rabbani, Fazle; Ali, Gohar; Zahoor, Nazish; Lawangeen, Sibtain; Awan, Naila Riaz // Journal of Pakistan Psychiatric Society;Jul-Dec2013, Vol. 10 Issue 2, p77 

    Objective: To assess the symptomatic and functional recovery with long duration of illness of schizophrenics at baseline and after at 5 years follow up Design: Descriptive observational study. Place and Duration of study: This study was conducted at department of Psychiatry Lady Reading Hospital...

  • Self-perception of quality of life in patients treated with antipsychotics. DIMA, Lorena; VASILE, Daniel; ROGOZEA, Liliana; ZIA-UL-HAQ, Muhammad; BUKHARI, Shazia Anwer; MOGA, Marius // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 4, p782 

    Background/aim: Despite extensive research, normal functionality remains problematic in patients with schizophrenia. Issues such as quality of life, subjective well-being, or psychosocial performance are currently objectives of interest. There are limited data collected prospectively on...

  • Bridging the science-to-service gap in schizophrenia care in the Netherlands: the Schizophrenia Quality Improvement Collaborative. Van Duin, Danielle; Franx, Gerdien; Van Wijngaarden, Bob; Van Der Gaag, Mark; Van Weeghel, Jaap; Slooff, Cees; Wensing, Michel // International Journal for Quality in Health Care;Dec2013, Vol. 25 Issue 6, p626 

    Objective Many patients with schizophrenia are not treated in line with evidence-based guidelines. This study examines the large-scale implementation of the National Multidisciplinary Guideline for schizophrenia in the Netherlands. Design Observational, prospective study, with repeated...

  • Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study. Srisurapanont, Manit; Likhitsathian, Surinporn; Boonyanaruthee, Vudhichai; Charnsilp, Chawanun; Jarusuraisin, Ngamwong // BMC Psychiatry;2007, Vol. 7, p14 

    Background: Not only the prevalence, but also the progress of metabolic abnormalities in schizophrenic patients is of importance for treatment planning and policy making. However, there have been very few prospective studies of metabolic disturbance in schizophrenic patients. This study aimed to...

  • Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness. Khatana, Sameed Ahmed M.; Kane, Joshua; Taveira, Tracey H.; Bauer, Mark S.; Wen-Chih Wu // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background: Cardiovascular disease is the leading cause of mortality among patients with serious mental illness (SMI) and the prevalence of metabolic syndrome-a constellation of cardiovascular risk factors-is significantly higher in these patients than in the general population. Metabolic...

  • Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Zhi-Jun Zhang; Zhi-Jian Yao; Wen Liu; Qun Fang; Reynolds, Gavin P. // British Journal of Psychiatry;Jan2004, Vol. 184, p58 

    Background Weight gain is a common consequence of antipsychotic drug treatment and can lead to further morbidity. Aims To assess the effects of antipsychotic drug therapy on abdominal fat deposition, on insulin and leptin secretion, and on circulating glucose and lipids. Method Abdominal body...

  • Olanzapine Increases Grey and White Matter Volumes in the Caudate Nucleus of Patients with Schizophrenia. Okugawa, Gaku; Nobuhara, Kenji; Takase, Katsunori; Saito, Yukiko; Yoshimura, Masafumi; Kinoshita, Toshihiko // Neuropsychobiology;2007, Vol. 55 Issue 1, p43 

    There are inconsistent reports regarding the caudate nucleus volume in patients with schizophrenia compared with healthy subjects. The reason for this is that neuroleptic medication may affect the volume of the caudate nucleus in schizophrenic patients. To clarify which antipsychotic medication...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics